Literature DB >> 18627330

Novelties in the multifaceted miconazole effects on skin disorders.

Pascale Quatresooz1, Valérie Vroome, Marcel Borgers, Geert Cauwenbergh, Gérald E Piérard.   

Abstract

BACKGROUND: Miconazole nitrate is a time-honored antifungal of the imidazole class.
OBJECTIVE: To revisit the various aspects of action of the drug in a dermatologic setting.
METHOD: Review of the current peer-reviewed publications. RESULTS/
CONCLUSION: Miconazole essentially inhibits 14alpha-demethylase, an enzyme required for the biosynthesis of ergosterol, which is the main sterol constituent of fungal cell membranes. Hence, toxic methylated sterols accumulate. Synthesis of triglycerides and phospholipids is also affected. In addition, miconazole also exhibits other ancillary mechanisms of action that probably participate in the therapeutic efficacy of the drug. The oxidative and peroxidative enzyme activities are altered leading to an intracellular build up of a toxic concentration of hydrogen peroxide. This may contribute to the deterioration of subcellular organelles and to cell necrosis. Farnesol synthesis is stimulated in Candida spp. leading to the prevention of yeast-to-mycelium formation. Overall, miconazole is fungistatic through its effect on ergosterol biosynthesis, but it may also have a fungicidal effect against a number of fungal species due to its effect on hydrogen peroxide accumulation. In addition, miconazole is active against a series of Gram-positive bacteria and has been shown to help the repair of the skin barrier function and to help mitigate some inflammatory cell reactions (such as in acne). To conclude, miconazole exerts multi-pronged effects both against pathogenic fungi and on skin physiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18627330     DOI: 10.1517/14656566.9.11.1927

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  2 in total

1.  The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial.

Authors:  Zhimin Yan; Xiaosong Liu; Yang Liu; Ying Han; Mei Lin; Wenmei Wang; Xiaobing Guan; Shengrong Zhu; Handong Zhang; Qintao Wang; Lihong Chou; Xinghao Zhu; Hong Hua
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

2.  Simultaneous Improvement of Dissolution Behavior and Oral Bioavailability of Antifungal Miconazole via Cocrystal and Salt Formation.

Authors:  Ksenia V Drozd; Alex N Manin; Denis E Boycov; German L Perlovich
Journal:  Pharmaceutics       Date:  2022-05-22       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.